Antiplatelet Therapy and Interventional Radiology (IVR)

Abstract

Antiplatelet therapy (AT) is necessary for in patients undergoing vascular interventional radiology (IVR). Especially for patients undergoing vascular IVR using stent, AT is needed not only during the periprocedural period, but also for life after the periprocedural period. However, some of these patients require suspension of AT if a need for surgery or biopsy arises, and some studies have reported that ischemic events may occur after cessation or modification of the AT in patients who have undergone vascular IVR. Therefore, physicians ordering suspension of AT require enough understanding of the risk of cessation of AT and on how to suspend AT without increasing the risk of ischemic events. In this article, we document not only standard AT administration, but also update evidence on the administration of AT in patients who have undergone vascular IVR.